Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CDW Corp. (CDW) vs 22nd Century Group Inc (XXII) Price & Performance

22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

CDW Corp. vs 22nd Century Group Inc — how do they compare? CDW Corp. trades at $136.05 (market cap $16.92B), while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). The key difference: CDW Corp. is far larger — about 11131.6× 22nd Century Group Inc's market cap, and CDW Corp. pays a 1.86% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.

CDWXXII
Market Cap
$16.92B$1.52M
Sector
TechnologyTechnology
52-Week High
$170.77$801.00
52-Week Low
$99.30$3.72
Enterprise Value
$22.52B-$6.71M
Dividend Yield
1.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CDW Corp.

CDW trades at $136.43, up 0.46% with mixed technical signals showing bearish overall momentum but bullish moving averages. The company reported strong Q2 2026 results with earnings beating estimates at $2.91 per share and revenue growth of 10% year-over-year, though margin compression remains a concern. Analyst consensus remains strongly bullish with 12 buy ratings and a $148.67 price target, representing 9% upside potential from current levels.

CDW benefits from strong AI infrastructure demand and consistent dividend payments, but faces margin pressure and CFO transition risks. The stock offers attractive valuation with P/E of 16.27 and P/S of 0.75, though high debt levels and competitive pressures warrant monitoring. Near-term catalysts include Q3 earnings and continued AI-driven infrastructure spending.

22nd Century Group Inc

XXII trades at $4.46, up 2.53% today, with a neutral technical signal and bearish moving averages. The company shows deep losses with a net income margin of -65.76% and negative ROE of -130.19%, though it beat earnings in Q3 2025. Recent news highlights VLN® retail expansion in California and New York, and a reverse stock split on June 12, 2026. Cash flow remains dependent on financing, with operating cash flow negative at -$7.72 million in 2025.

Outlook is speculative; analyst consensus is 75% buy with growth potential from VLN® market expansion, but high execution and regulatory risks persist. Investment hinges on revenue scaling to offset persistent losses, with stock volatility expected near key resistance at $5.

Returns comparison

Trailing returns across standard periods

About CDW Corp.

CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.

Read more on CDW

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII